Protopanaxadiol and Protopanaxatriol-Type Saponins Ameliorate Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus in High-Fat Diet/Streptozocin-Induced Mice

被引:55
作者
Deng, Jianjun [1 ,2 ]
Liu, Yao [1 ,2 ]
Duan, Zhiguang [1 ,2 ]
Zhu, Chenhui [1 ,2 ]
Hui, Junfeng [1 ,2 ]
Mi, Yu [1 ,2 ]
Ma, Pei [1 ,2 ]
Ma, Xiaoxuan [1 ,2 ]
Fan, Daidi [1 ,2 ]
Yang, Haixia [3 ]
机构
[1] Northwest Univ, Dept Food Sci & Engn, Sch Chem Engn, Shaanxi Key Lab Degradable Biomed Mat, Xian, Shaanxi, Peoples R China
[2] Northwest Univ, Sch Chem Engn, Shaanxi R&D Ctr Biomat & Fermentat Engn, Xian, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Coll Publ Hlth, Dept Nutr & Food Safety, Xian, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
protopanaxadiol-type saponins; protopanaxatriol-type saponins; type 2 diabetes mellitus; inflammation; glucose metabolism; lipid metabolism; PANAX-GINSENG; INSULIN-RESISTANCE; HEPATIC GLUCONEOGENESIS; OXIDATIVE STRESS; RATS; ANTIOXIDANT; CELLS; AMPK; HYPERGLYCEMIA; ACTIVATION;
D O I
10.3389/fphar.2017.00506
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ginsenoside is a major active component of ginseng, which exhibits various pharmacological properties such as hepatoprotection, tumor suppression and diabetes resistance. In this study, the anti-diabetic effects of protopanaxadiol (PPD) and protopanaxatriol (PPT)-type saponins were explored and compared in high-fat diet/streptozocin-induced type 2 diabetes mellitus (T2DM) mice. Our results showed that low or high dose (50 mg/kg bodyweight or 150 mg/kg bodyweight) PPD and PPT significantly reduced fasting blood glucose, improved glucose tolerance and insulin resistance in T2DM mice. PPD and PPT also regulated serum lipid-related markers such as reduced total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol in T2DM mice. In addition, PPD and PPT dramatically ameliorated the inflammatory responses by suppressing the secretion of pro-inflammatory cytokines like tumor necrosis factor-alpha and interleukin-6 in serum level and gene expression in liver level, and improved the antioxidant capacity by increasing the superoxide dismutase and decreasing malondialdehyde levels in the serum of T2DM mice. Moreover, the anti-diabetic effect of PPD and PPT appeared to be partially mediated by the suppression of hepatic metabolism genes expression such as peroxisome proliferator-activated receptor gamma coactivator 1-alpha, phosphoenolpyruvate carboxykinase, and glucose-6-phosphatase, as well as facilitating lipid metabolism genes expression such as microsomal TG transfer protein in the liver tissues of T2DM mice. Taken together, our results indicated that PPD and PPT might potentially act as natural anti-diabetic compounds to be used for preventing and treating the T2DM and its complications in the future.
引用
收藏
页数:11
相关论文
共 46 条
[1]   Oxidative stress impairs skeletal muscle repair in diabetic rats [J].
Aragno, M ;
Mastrocola, R ;
Catalano, MG ;
Brignardello, E ;
Danni, O ;
Boccuzzi, G .
DIABETES, 2004, 53 (04) :1082-1088
[2]  
Basch Ethan, 2003, Altern Med Rev, V8, P20
[3]  
Bibak Bahram, 2014, Adv Biomed Res, V3, P173, DOI 10.4103/2277-9175.139191
[4]   Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB [J].
Cai, DS ;
Yuan, MS ;
Frantz, DF ;
Melendez, PA ;
Hansen, L ;
Lee, J ;
Shoelson, SE .
NATURE MEDICINE, 2005, 11 (02) :183-190
[5]   Q&A: Five questions on the 2015 IDF Diabetes Atlas [J].
Cho, Nam Han .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 115 :157-159
[6]   Altered expression of serum protein in ginsenoside Re-treated diabetic rats detected by SELDI-TOF MS [J].
Cho, William C. S. ;
Yip, Tai-Tung ;
Chung, Wai-Shing ;
Lee, Sally K. W. ;
Leung, Albert W. N. ;
Cheng, Christopher H. K. ;
Yue, Kevin K. M. .
JOURNAL OF ETHNOPHARMACOLOGY, 2006, 108 (02) :272-279
[7]   Ginsenoside, Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats [J].
Cho, William C. S. ;
Chung, Wai-Shing ;
Lee, Sally K. W. ;
Leung, Albert W. N. ;
Cheng, Christopher H. K. ;
Yue, Kevin K. M. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 550 (1-3) :173-179
[8]   The effect of rosiglitazone on the liver: Decreased gluconeogenesis in patients with type 2 diabetes [J].
Gastaldelli, A ;
Miyazaki, Y ;
Pettiti, M ;
Santini, E ;
Ciociaro, D ;
DeFronzo, RA ;
Ferrannini, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) :806-812
[9]  
Giacco B., 2010, TXB DIABETES
[10]   Inflammation, cancer, and targets of ginseng [J].
Hofseth, Lorne J. ;
Wargovich, Michael J. .
JOURNAL OF NUTRITION, 2007, 137 (01) :183S-185S